The development of multiple bladder tumor recurrences in relation to the FGFR3 mutation status of the primary tumor

被引:0
|
作者
Kompier, Lucie
van Tilborg, Angela
van der Aa, Madelon
Lurkin, Irene
Vermeij, Marcel
Kirkels, Wim
Bangma, Chris
van der Kwast, Theo
Zwarthoff, Ellen
机构
[1] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[3] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1644
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour
    Kompier, Lucie C.
    van der Aa, Madelon N. M.
    Lurkin, Irene
    Vermeij, Marcel
    Kirkels, Wim J.
    Bangma, Chris H.
    van der Kwast, Theodorus H.
    Zwarthoff, Ellen C.
    JOURNAL OF PATHOLOGY, 2009, 218 (01): : 104 - 112
  • [2] Distinct tumor microenvironment in FGFR3 Alternations for Bladder Cancer
    Komura, Kazumasa
    Nishimura, Kazuki
    Tsujino, Takuya
    Inamoto, Teruo
    Taniguchi, Kohei
    Hayashi, Takuo
    Hirose, Yoshinobu
    Shiraishi, Yuichi
    Yoshimi, Akihide
    Azuma, Haruhito
    CANCER SCIENCE, 2024, 115 : 250 - 250
  • [3] FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?
    van Rhijn, Bas W. G.
    Mertens, Laura S.
    Mayr, Roman
    Bostrom, Peter J.
    Real, Francisco X.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Abas, Cheno
    van Leenders, Geert J. l H.
    Gotz, Stefanie
    Hippe, Katrin
    Bertz, Simone
    Neuzillet, Yann
    Sanders, Joyce
    Broeks, Annegien
    van der Heijden, Michiel S.
    Jewett, Michael A. S.
    Marquez, Mirari
    Stoehr, Robert
    Zlotta, Alexandre R.
    Eckstein, Markus
    Soorojebally, Yanish
    Roshani, Hossain
    Burger, Maximilian
    Otto, Wolfgang
    Radvanyi, Francois
    Sirab, Nanor
    Pouessel, Damien
    Wullich, Bernd
    van der Kwast, Theo H.
    Malats, Nuria
    Hartmann, Arndt
    Allory, Yves
    Zuiverloon, Tahlita C. M.
    EUROPEAN UROLOGY, 2020, 78 (05) : 682 - 687
  • [4] Significance of the FGFR3 mutation in Chinese patients with bladder cancer
    Hao, Lanxiang
    Fang, Jiang
    Xu, Ran
    Liu, Shuo
    Luo, Guangcheng
    Wang, Xinjun
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (05) : 761 - +
  • [5] FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
    Tomlinson, D. C.
    Baldo, O.
    Hamden, P.
    Knowles, M. A.
    JOURNAL OF PATHOLOGY, 2007, 213 (01): : 91 - 98
  • [6] FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
    Guancial, Elizabeth A.
    Werner, Lillian
    Bellmunt, Joaquim
    Bamias, Aristotle
    Choueiri, Toni K.
    Ross, Robert
    Schutz, Fabio A.
    Park, Rachel S.
    O'Brien, Robert J.
    Hirsch, Michelle S.
    Barletta, Justine A.
    Berman, David M.
    Lis, Rosina
    Loda, Massimo
    Stack, Edward C.
    Garraway, Levi A.
    Riester, Markus
    Michor, Franziska
    Kantoff, Philip W.
    Rosenberg, Jonathan E.
    CANCER MEDICINE, 2014, 3 (04): : 835 - 844
  • [7] Identification of FGFR3 mutations in urine sediment DNA complements cytology in bladder tumor detection
    Mourtzinos, AP
    Rieger-Christ, KM
    Cain, J
    Silverman, M
    Libertino, JA
    Summerhayes, IC
    JOURNAL OF UROLOGY, 2003, 169 (04): : 132 - 132
  • [8] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Kazumasa Komura
    Kensuke Hirosuna
    Satoshi Tokushige
    Takuya Tsujino
    Kazuki Nishimura
    Mitsuaki Ishida
    Takuo Hayashi
    Ayako Ura
    Takaya Ohno
    Shogo Yamazaki
    Keita Nakamori
    Shoko Kinoshita
    Ryoichi Maenosono
    Masahiko Ajiro
    Yuki Yoshikawa
    Tomoaki Takai
    Takeshi Tsutsumi
    Kohei Taniguchi
    Tomohito Tanaka
    Kiyoshi Takahara
    Tsuyoshi Konuma
    Teruo Inamoto
    Yoshinobu Hirose
    Fumihito Ono
    Yuichi Shiraishi
    Akihide Yoshimi
    Haruhito Azuma
    Molecular Cancer, 22
  • [9] novel somatic FGFR3 mutation in primary lung cancer
    Shinmura, Kazuya
    Kato, Hisami
    Matsuura, Shun
    Inoue, Yusuke
    Igarashi, Hisaki
    Nagura, Kiyoko
    Nakamura, Satoki
    Maruyama, Kyoko
    Tajima, Mari
    Funai, Kazuhito
    Ogawa, Hiroshi
    Tanahashi, Masayuki
    Niwa, Hiroshi
    Sugimura, Haruhiko
    ONCOLOGY REPORTS, 2014, 31 (03) : 1219 - 1224
  • [10] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Komura, Kazumasa
    Hirosuna, Kensuke
    Tokushige, Satoshi
    Tsujino, Takuya
    Nishimura, Kazuki
    Ishida, Mitsuaki
    Hayashi, Takuo
    Ura, Ayako
    Ohno, Takaya
    Yamazaki, Shogo
    Nakamori, Keita
    Kinoshita, Shoko
    Maenosono, Ryoichi
    Ajiro, Masahiko
    Yoshikawa, Yuki
    Takai, Tomoaki
    Tsutsumi, Takeshi
    Taniguchi, Kohei
    Tanaka, Tomohito
    Takahara, Kiyoshi
    Konuma, Tsuyoshi
    Inamoto, Teruo
    Hirose, Yoshinobu
    Ono, Fumihito
    Shiraishi, Yuichi
    Yoshimi, Akihide
    Azuma, Haruhito
    MOLECULAR CANCER, 2023, 22 (01)